SHINECO, INC.: M&A transaction — Shineco closes acquisition of 75% of FuWang (HK) for ~US$8.9M cash plus stock

SHINECO, INC.

Shineco Life Science acquired 75% equity in FuWang (HK) from Yi Yang on May 12, 2025.
Consideration: RMB 63.89M (~US$8.9M) cash, 3,400,000 Shineco shares, and 71.42% of Dream Partner Ltd.
Shares issued under Regulation S; seller represented as non-U.S. person.
Financial statements and pro forma financials to be filed by amendment within 71 days.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

SHINECO, INC. completed an acquisition involving Yi Yang for RMB 63.89 million (approximately US$8.9 million) in cash, 3,400,000 shares of common stock, and 71.42% equity interests in Dream Partner Limited (closed 2025-05-12).

Action: acquisition
Counterparty: Yi Yang
Consideration: RMB 63.89 million (approximately US$8.9 million) in cash, 3,400,000 shares of common stock, and 71.42% equity interests in Dream Partner Limited
Closing: 2025-05-12

Exact text from the filing

in FuWang (HK) to Shineco Life Science; therefore, FuWang (HK) became a direct subsidiary of Shineco Life Science. In exchange, Shineco Life Science paid to the Seller RMB 63.89 million (approximately US$8.9 million) in cash, and the Company issued 3,400,000 shares of the Company’s common stock, par value $0.001 per share (the “Shares”) and transferred the

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001641172-25-009945

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.